History
Kinesciences will always be a company that
remains in the minds of customers without losing its original intentions.
2023
- 12
- KINE-101C IND filling
- 11
- Research Collaboration Agreement with IMMUNIQUE
- 10
- KINE-101A completed Phase 1 in US FDA
2022
- 03
- CEOs of Hee Kyung Kim & Dae Ho Cho inaugurated
- 01
- KINE-101B GLP study initiated
2021
- 12
- Move the head office to PNM Tower
- 09
- KINE-101A Phase 1 IND approved by US FDA
- 05
- Substance patents regarding KINE-101,
KINE-201 and KINE-301 registered in US
2020
- 07
- Project awarded by Korea Patent Strategy Development Institute
2019
- 08
- Corporate R&D Center certification acquisition
- 07
- KINE-101A GLP study initiated
- 03
- R&D Center of KINE SCIENCES established
- 03
- Change of corporate name to KINE SCIENCES Co.,Ltd.
2018
- 12
- Certified by Korea Government as a Venture Company
- 10
- Established joint research institute with Korea University
2017
- 12
- Patents regarding KINE-101, KINE-201 and KINE-301 filed in
major foreign conturies
2016
- 12
- Selected as a new drug development project by the Ministry of
New Drug Development Project
- 08
- Company founded(Bio Pep Co., Ltd.)